Unlocking the Power of Evidence: Upcoming Workshop on Network Meta-Analysis

Unlocking the Power of Evidence: Upcoming Workshop on Network Meta-Analysis

Imagine trying to choose the best treatment when dozens of studies compare different options — but not always head-to-head. How do you know which one really works best?

That’s where network meta-analysis (NMA) comes in. NMA allows researchers and guideline developers to compare multiple interventions simultaneously, even when direct comparisons are missing. It’s a powerful tool for making sense of complex evidence, and it’s increasingly shaping clinical practice guidelines around the world.

This January, you’ll have the chance to sharpen your skills in NMA with guidance from global experts.

About the Workshop

The U.S. GRADE Network is hosting a fully virtual, two-day workshop on January 12–13, 2026. Whether you’re a systematic reviewer, clinician, policy-maker, or researcher, this course is designed to help you get hands-on experience with NMA and understand how to apply it in your work.

Over the course of two days, participants will:

  • Work through real-world examples of intransitivity and incoherence.
  • Learn how to apply the GRADE framework to network meta-analyses.
  • Gain practical experience in using R software to conduct and interpret NMAs.

The program balances theory with practice, ensuring you walk away with both the concepts and the skills to use NMA confidently.

Scholarships Available

To make the workshop more accessible, a limited number of scholarships are available to cover registration. Applications are open now and close on September 30, 2025. Visit the Evidence Foundation website for details and to apply.

Register Today

Registration is now open at www.systematicreview.org.

If you’re interested in improving the way evidence is synthesized, communicated, and translated into decisions, this workshop is for you. Don’t miss this opportunity to join colleagues from around the world in exploring one of the most powerful tools in evidence-based medicine.